Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Prezacor
AddedFeb 15, 2024
UpdatedJun 18, 2026
Prezacor

Prezacor

Public

Prezacor Inc.: A US-based provider of innovative pain management treatments, specializing in neck and back pain.

HQ
Princeton, NJ, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize pain management, Prezacor Inc. is a US-based company dedicated to developing and marketing advanced treatments for neck and back pain. The company's vision is to enhance the quality of life for individuals suffering from chronic pain through innovative medications and patches. Prezacor's product line includes a variety of pain relief options designed to address different levels of discomfort, ensuring comprehensive care for its users.

Prezacor has garnered attention from notable figures in the healthcare industry and has attracted investment from key players in medical technology. The company's achievements include the successful launch of several effective pain management products, which have been well-received in the market. Prezacor's impact is evident in its growing customer base and positive feedback from patients who have experienced significant relief from their chronic pain conditions.

Prezacor - Similar Companies

Pacira BioSciences logo

Pacira BioSciences

pacira.com

Prevacus logo

Prevacus

Solace Pharmaceuticals logo

Solace Pharmaceuticals

NeuraLace Medical logo

NeuraLace Medical

Prexa Pharmaceuticals logo

Prexa Pharmaceuticals

Doloromics logo

Doloromics

doloromics.com

Praetego logo

Praetego

praetego.com

Global Pain Center logo

Global Pain Center

Sarentis Therapeutics logo

Sarentis Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Trigemina logo

Trigemina

Concentric Analgesics logo

Concentric Analgesics

Praeventix logo

Praeventix

praeventix.com

Patient Premier logo

Patient Premier

patientpremier.com

PreventScripts logo

PreventScripts

Prezacor - Quick Facts

Who are Prezacor's competitors?

Companies similar to Prezacor include Pacira BioSciences, Prevacus, Solace Pharmaceuticals and NeuraLace Medical.

When was Prezacor founded?

Prezacor was founded in 2005.

Where is Prezacor's headquarters located?

Prezacor's headquarters is located in Princeton, NJ, US.

When was Prezacor's last funding round?

Prezacor's most recent funding round was for $250k (USD) in January 2012.

How much has Prezacor raised to-date?

As of Jan 16, 2012, Prezacor has raised a total of $250k (USD).

How many employees does Prezacor have?

Prezacor has 6 employees as of Feb 5, 2024.

Prezacor - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Pain Management
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified